We demonstrated that in vivo depletion of Tregs and CD8+ T cells in FBL-3-bearing DEREG transgenic mice augments GzmB production by CD4+ T cells and increases FV-specific CD4+ T-cell effector and cytotoxic responses leading to the complete tumor regression. This evidence concerns the gene CD4 and neoplasm.